Immunic (IMUX) Accumulated Depreciation (2013 - 2015)

Immunic has reported Accumulated Depreciation for 3 years, with the latest figure at $7.4 million in Q2 2015.

• Quarterly Accumulated Depreciation rose 16.85% year-over-year to $7.4 million in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $7.4 million (up 16.85% YoY) and the FY2014 annual result came in at $6.8 million, up 17.78% from the prior year.
• Accumulated Depreciation climbed to $7.4 million in Q2 2015 per IMUX's latest filing, from $7.1 million in the prior quarter.
• Over five years, Accumulated Depreciation peaked at $7.4 million in Q2 2015 and troughed at $5.8 million in Q4 2013.
• A 3-year average of $6.6 million and a median of $6.6 million in 2014 frame the typical range for Accumulated Depreciation.
• The sharpest annual moves came in 2014 and 2015: Accumulated Depreciation advanced 17.78% in 2014, then climbed 16.85% in 2015.
• Over 3 years, Accumulated Depreciation stood at $5.8 million in 2013, then increased by 17.78% to $6.8 million in 2014, then gained by 8.57% to $7.4 million in 2015.
• According to Business Quant data, Accumulated Depreciation over the past three periods registered $7.4 million, $7.1 million, and $6.8 million for Q2 2015, Q1 2015, and Q4 2014 respectively.